NCT06705335View on ClinicalTrials.gov

Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2029

Conditions
Pancreas Cancer
Interventions
OTHER

Blood sample

On the same day as the tumour sample is taken (biopsy or surgery), a blood sample of approximately 15 to 20 mL is taken in EDTA-free tubes.

Sponsors

Lead Sponsor

Institut Bergonié
All Listed Sponsors
lead

Institut Bergonié

OTHER

NCT06705335 - Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter